NISN yields 294.12% · JNJ yields 2.13%● Live data
📍 NISN pulled ahead of the other in Year 1
Combined, NISN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NISN + JNJ for your $10,000?
Nisun International Enterprise Development Group Co., Ltd, an investment holding company, provides technology-driven integrated supply chain solutions for enterprises and financial institutions in the People's Republic of China and internationally. It offers professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions. The company also provides a range of technology-driven customized financing solutions to small- and mid-sized enterprises (SMEs) to enhance SMEs' access to capital through its closed-loop ecosystem built on fintech platforms; and direct banking solutions to small- and medium-sized commercial banks and other financial institutions in their distribution and management of direct banking and other financial products. Nisun International Enterprise Development Group Co., Ltd has a strategic collaboration with Henan Wanbang International Agricultural Products Logistics Co., Ltd. for cooperation on businesses related to the agricultural field. The company was formerly known as Hebron Technology Co., Ltd. and changed its name to Nisun International Enterprise Development Group Co., Ltd in September 2020. Nisun International Enterprise Development Group Co., Ltd was founded in 2005 and is headquartered in Shanghai, the People's Republic of China.
Full NISN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.